In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, with AstraZeneca revealing "encouraging data" out of its Phase I study of its obesity and diabetes drug AZD5004.Continue ReadingCategory: Obesity, Illnesses and conditions, Body & MindTags: AstraZeneca, Ozempic, Obesity, Weight Loss, Diabetes, GLP1, Drugs, clinical trials

Who Voted for this Story



Clickiz.com is a social bookmarking place where you can share, find & discuss the best news around on most topics. We focus on hi-tech reviews, gadgets and geekery but we like almost anything that's awesome, appealing and thought-provoking! er6i9ds5mz




Add to Technorati Favorites
Username:

Password:

Remember: